XML 127 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating activities:    
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 25,088 $ 22,505
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]    
Depreciation and amortization 22,482 20,893
Deferred income taxes and related valuation allowance (6,097) (698)
Net loss (gain) on sale of real estate, investments and other (302) 852
Stock-based compensation 5,264 3,629
Amortization of deferred financing costs 1,106 860
Unrealized Gain (Loss) on Derivatives 554 (714)
Gain (Loss) on Sale of Assets and Asset Impairment Charges 0 (175)
Other Operating Activities, Cash Flow Statement 4,684 3,843
Changes in operating assets and liabilities, net of effects of business acquisitions:    
Trade accounts receivable (11,409) 381
Inventories (22,415) (30,754)
Prepaid expenses and other (5,868) 2,321
Increase (Decrease) in Other Operating Assets 357 24
Trade accounts payable (5,996) (11,267)
Increase (Decrease) in Accrued Liabilities (3,085) (3,124)
Increase (Decrease) in Other Noncurrent Liabilities (4,921) (2,545)
Net cash provided by (used for) operating activities (558) 6,149
INVESTING ACTIVITIES:    
Proceeds from Sale and Maturity of Marketable Securities 1,100 1,900
Payments to Acquire Marketable Securities (1,809) (2,709)
Payments to Acquire Property, Plant, and Equipment (10,319) (5,288)
Proceeds from Sale of Property, Plant, and Equipment 0 373
Proceeds from Equity Method Investment, Distribution, Return of Capital 144 313
Payments to Acquire Businesses, Net of Cash Acquired (108,145) (1,616)
Net cash provided by (used for) investing activities (119,029) (7,027)
FINANCING ACTIVITIES:    
Proceeds from the issuance of common stock 492 621
Repayment of debt (25,294) (20,264)
Proceeds from Issuance of Long-term Debt 120,000 0
Proceeds from Issuance or Sale of Equity (2,859) 0
Proceeds from Derivative Instrument, Financing Activities 12,084 12,306
Payments for Derivative Instrument, Financing Activities (12,660) (11,689)
Payments of Dividends (4,015) (4,001)
Other (1,954) (1,375)
Net cash provided by (used for) financing activities 85,794 (24,402)
Effect of exchange rate changes on cash (325) (1,245)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (34,118) (26,525)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents 99,308 89,115
Capital Expenditures Incurred but Not yet Paid 1,260 0
Gain (Loss) on Disposition of Property Plant Equipment 0 (232)
Supplementary cash flow data:    
Interest Paid, Excluding Capitalized Interest, Operating Activities 16,054 12,045
Income taxes paid, net of refunds 15,183 10,271
Restricted Cash $ 250 $ 250